Eunited Infotech - News Feeds

News Feeds
Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

White House open to compromise over contraception: adviser WASHINGTON (Reuters) - The Obama administration is willing to work with Catholic universities and hospitals in implementing new rules that require health insurance to cover birth control, a top adviser to the president's re-election campaign said on Tuesday. Komen VP steps down after Planned Parenthood flap WASHINGTON (Reuters) - A senior executive of the breast cancer charity Susan G. Komen for the Cure has resigned after a public outcry over the group's decision to cut funding to women's health organization Planned Parenthood. Behavior programs may cut child obesity risk NEW YORK (Reuters Health) - Programs that teach parenting skills early on may help prevent obesity in poor U.S. kids, a study published Monday suggests. Obama administration to spend $50 million more on Alzheimer's (Reuters) - The Obama administration said on Tuesday it will spend an additional $50 million immediately to bolster research for Alzheimer's, a fatal, brain-wasting disease that affects 5 million Americans. Walmart to label healthier food as "Great For You" (Reuters) - After a lengthy debate, Walmart decided that eggs are indeed healthy. "Malaria cure" claim sparks Vienna probe VIENNA (Reuters) - A Vienna hospital is searching for long-retired staff who might hold clues to a man's claim that he was deliberately infected with malaria when he was a psychiatric patient nearly half a century ago. Diet supplements recalled on unlabeled drug worries WASHINGTON (Reuters) - Healthy People Co is recalling 15 lots of seven different dietary supplements because they contain appetite suppressants or a drug for male erectile dysfunction, the Long Beach, California, company said. FDA staff unsure about new use for Amgen's Xgeva WASHINGTON (Reuters) - Reviewers from Food and Drug Administration said they were not sure whether Amgen Inc's Xgeva bone drug should be also approved as a treatment to delay the spread of cancer to the bone. Ovarian cancer screening popular despite guidelines NEW YORK (Reuters Health) - Despite expert guidelines and scientific evidence to the contrary, a third of U.S. primary care physicians believe ovarian cancer screening is effective and many would offer it to patients, according to a new survey. Blurry line in diagnosing early Alzheimer's: study NEW YORK (Reuters Health) - The revised definition of a brain condition called mild cognitive impairment means that many people now considered to have mild or early Alzheimer's disease could easily be given that diagnosis instead, suggests a new study.

[ Back ]

Customer Login

Login Form